News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
834,028 Results
Type
Article (85785)
Company Profile (649)
Press Release (747594)
Section
Business (232070)
Career Advice (4121)
Deals (39689)
Drug Delivery (124)
Drug Development (90696)
Employer Resources (195)
FDA (17950)
Job Trends (17295)
News (395248)
Policy (39616)
Tag
Academia (2977)
Alliances (56563)
Alzheimer's disease (1401)
Antibody-drug conjugate (ADC) (111)
Approvals (17930)
Artificial intelligence (182)
Bankruptcy (399)
Best Places to Work (12511)
Biotechnology (447)
Breast cancer (188)
Cancer (1542)
Career advice (3523)
CAR-T (130)
Cell therapy (376)
Clinical research (72158)
Collaboration (625)
Compensation (313)
COVID-19 (2808)
C-suite (150)
Data (1393)
Diabetes (151)
Diagnostics (6700)
Earnings (94479)
Employer resources (166)
Events (127271)
Executive appointments (483)
FDA (18657)
Funding (522)
Gene therapy (262)
GLP-1 (685)
Government (5051)
Healthcare (20710)
Infectious disease (2899)
Inflammatory bowel disease (134)
Interviews (810)
IPO (17657)
Job creations (5182)
Job search strategy (2859)
Layoffs (510)
Legal (10038)
Lung cancer (234)
Manufacturing (225)
Medical device (14271)
Medtech (14276)
Mergers & acquisitions (22168)
Metabolic disorders (487)
Neuroscience (1784)
NextGen: Class of 2025 (7661)
Non-profit (5053)
Northern California (1847)
Obesity (266)
Opinion (259)
Patents (142)
People (64502)
Pharmaceutical (131)
Phase I (22285)
Phase II (31377)
Phase III (23581)
Pipeline (638)
Postmarket research (3541)
Preclinical (9997)
Radiopharmaceuticals (246)
Rare diseases (305)
Real estate (7375)
Regulatory (26140)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1575)
Startups (4277)
United States (16258)
Vaccines (668)
Weight loss (205)
Date
Last 7 days (501)
Last 30 days (2044)
Last 365 days (32020)
2025 (3673)
2024 (34033)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1262)
Arizona (226)
Asia (49549)
Australia (8749)
California (4212)
Canada (1368)
China (373)
Colorado (136)
Connecticut (180)
Europe (113372)
Florida (509)
Georgia (113)
Illinois (397)
Indiana (228)
Maryland (716)
Massachusetts (3377)
Michigan (169)
Minnesota (277)
New Jersey (1199)
New York (1179)
North Carolina (892)
Northern California (1847)
Ohio (141)
Pennsylvania (913)
South America (1646)
Southern California (1575)
Texas (553)
Washington State (445)
834,028 Results for "tela bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025
·
2 min read
Business
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
TELA Bio, Inc. announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company that operates as a stand-alone business within Johnson & Johnson’s MedTech Segment, to its Board of Directors, effective June 4, 2024.
June 4, 2024
·
3 min read
Business
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.
May 20, 2024
·
5 min read
Business
TELA Bio to Announce First Quarter 2024 Financial Results
TELA Bio, Inc. today announced that the Company will report first quarter 2024 financial results on Thursday, May 9, 2024.
April 25, 2024
·
2 min read
Press Releases
TELA Bio Reports Third Quarter 2024 Financial Results
November 8, 2024
·
9 min read
Business
TELA Bio Reports First Quarter 2024 Financial Results
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
8 min read
Press Releases
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
November 19, 2024
·
1 min read
Press Releases
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024
December 16, 2024
·
2 min read
Pharm Country
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 10, 2024
TELA Bio, Inc. announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024.
May 10, 2024
·
2 min read
Business
TELA Bio to Announce Third Quarter 2024 Financial Results
October 17, 2024
·
2 min read
1 of 83,403
Next
